Company Monitoring Page for Vertex

latest headlines for company on cafepharma

Vertex boosts cell and genetic therapies toolkit in deal worth up to $1.2bn with Arbor
Biopharma Reporter
Mon, 08/30/21 - 10:57 am
Tags:
Vertex, cell therapy, gene therapy, CRISPR, gene editing, Arbor Biotechnologies
Vertex begins human testing for diabetes cell therapy
BioPharma Dive
Wed, 03/10/21 - 10:46 pm
Tags:
Vertex, type 1 diabetes, cell therapy, VX-880
New CRISPR, gene therapy results strengthen potential for treatment of blood diseases
BioPharma Dive
Fri, 06/12/20 - 11:11 am
Tags:
CRISPR, gene therapy, beta thalassemia, sickle cell disease, CRISPR Therapeutics, Vertex, Bluebird Bio, EHA
Vertex’s Cystic-Fibrosis Drug Faces Big Test
WSJ Online
Sun, 05/10/15 - 09:53 am
Tags:
Vertex, cystic fibrosis, FDA, Orkambi
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
Tags:
drug pricing, Soliris, Alexion, Naglazyme, Biomarin, Kalydeco, Vertex, Cinryze, Shire, Sprycel, Bristol-Myers Squibb, Pomalyst, Celgene, Xyrem, Jazz Pharmaceuticals, Erbitux, Merck KGaA, Revlimid, Questcor, Mallinckrodt, H.P. Acthar Gel
Biotech Stocks Get Turbo Boost From Idenix Deal
Seeking Alpha
Thu, 06/12/14 - 09:33 am
Tags:
M&A, Merck, Idenix, Achillion, Agios, Alkermes, Celldex Therapeutics, Vertex, Seattle Genetics, Epizyme
Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014
Seeking Alpha
Fri, 01/3/14 - 11:41 am
Tags:
Gilead Sciences, hepatitis C, Merck, Sovaldi, Vertex
Vertex Cystic Fibrosis Trial Has Good, Bad News
Investors.com
Thu, 12/19/13 - 11:50 am
Tags:
Vertex, cystic fibrosis, Kalydeco
Vertex Building A Fortress In Cystic Fibrosis
Investopedia
Wed, 08/28/13 - 04:41 pm
Tags:
Vertex, cystic fibrosis, Gilead, GSK, Kalydeco, Bristol-Myers Squibb
Inside HCV: An Interview with Janssen
Motley Fool
Thu, 06/13/13 - 10:54 am
Tags:
hepatitis C, Janssen, Gilead, JNJ, Vertex, simeprevir, sofosbuvir
Vertex strengthens warning with hepatitis C drug
Reuters
Wed, 12/19/12 - 01:31 pm
Tags:
Vertex, hepatitis C, Incivek
Vertex to collaborate with Janssen on Phase 2 all-oral study for hepatitis C
The Fly on the Wall
Thu, 11/1/12 - 10:05 am
Tags:
Vertex, Janssen, hepatitis C, simeprevir, VX-135
Cataract risk for kids on Vertex's cystic fibrosis pill -FDA
Reuters
Wed, 08/29/12 - 12:15 pm
Tags:
cataracts, FDA, cystic fibrosis, Vertex, Kalydeco
Hepatitis C testing may lift Vertex’s market
The Boston Globe, MA
Sat, 08/18/12 - 04:21 pm
Tags:
hepatitis C, Vertex, Incivek
An Assault On Vertex, Enthusiasm Building Around Xoma
Seeking Alpha
Fri, 07/6/12 - 12:46 pm
Tags:
Xoma, Vertex
Vertex Could Fly High on Cystic Fibrosis Projects
Motley Fool
Mon, 06/18/12 - 02:39 pm
Tags:
cystic fibrosis, Vertex
Vertex's Cystic Fibrosis Drug Impresses Investors
Seeking Alpha
Sun, 05/13/12 - 01:15 pm
Tags:
Vertex, cystic fibrosis, VX-809, Kalydeco
Vertex Is Ready To Rise On INCIVEK Success
Seeking Alpha
Wed, 04/25/12 - 03:38 pm
Tags:
Incivek, Vertex, hepatitis C, Abbott Laboratories, Amgen, Bristol-Myers Squibb, Gilead, Merck, Pfizer
Vertex Hopes Two Cystic Fibrosis Drugs Better than One
TheStreet.com
Tue, 04/24/12 - 10:36 am
Tags:
cystic fibrosis, Vertex, Gilead, Bristol-Myers Squibb, Indenix, Kalydeco, VX-809
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Seeking Alpha
Sat, 04/21/12 - 12:17 pm
Tags:
Vertex, Incivek, ABT-072, ABT-450, Abbott Laboratories, Achillion, ACH-1625, ACH-2684, ACH-2928, ACH-3102, TMC435, JNJ, GSK, hepatitis C

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.